Table 4.
Factorial and interaction analysis of metabolic factors.
| Mixed linear model | F | p | |
|---|---|---|---|
| Lnhs-CRP | DS | 4.14 | 0.017 |
| HM | 2.168 | 0.115 | |
| DS ∗ HM | 0.31 | 0.734 | |
| LnTNF | DS | 0.764 | 0.466 |
| HM | 1.733 | 0.177 | |
| DS ∗ HM | 0.579 | 0.561 | |
| LnADI | DS | 1.423 | 0.241 |
| HM | 0.828 | 0.437 | |
| DS ∗ HM | 0.638 | 0.505 | |
| LnLEP | DS | 9.676 | 0 |
| HM | 4.058 | 0.017 | |
| DS ∗ HM | 1.191 | 0.304 | |
| LnINS | DS | 35.824 | 0 |
| HM | 10.349 | 0 | |
| DS ∗ HM | 2.606 | 0.074 | |
| TC | DS | 0.363 | 0.696 |
| HM | 2.226 | 0.108 | |
| DS ∗ HM | 1.048 | 0.351 | |
| TG | DS | 13.974 | 0 |
| HM | 4.401 | 0.012 | |
| DS ∗ HM | 1.445 | 0.236 | |
| HDL-c | DS | 1.738 | 0.176 |
| HM | 6.567 | 0.001 | |
| DS ∗ HM | 2.609 | 0.074 | |
| LDL-c | DS | 3.31 | 0.037 |
| HM | 0.459 | 0.632 | |
| DS ∗ HM | 2.395 | 0.092 | |
| GLU | DS | 9.095 | 0 |
| HM | 0.738 | 0.478 | |
| DS ∗ HM | 2.455 | 0.086 | |
| FFA | DS | 5.746 | 0.003 |
| HM | 0.833 | 0.435 | |
| DS ∗ HM | 1.115 | 0.328 | |
| HbA1C% | DS | 1.349 | 0.26 |
| HM | 1.319 | 0.268 | |
| DS ∗ HM | 1.21 | 0.298 | |
| HOMAIR | DS | 25.728 | 0 |
| HM | 6.568 | 0.001 | |
| DS ∗ HM | 2.836 | 0.059 | |
| HOMAIS | DS | 28.597 | 0 |
| HM | 7.57 | 0.001 | |
| DS ∗ HM | 0.064 | 0.938 |
Note. Single-factor variance analysis was used, where p < 0.05 denotes a statistically significant difference.
P: placebo; DS: dietary supplements; GM: general management, H: health management.
DS ∗ HM: cross function of dietary supplements and health management.